Shanghai Kaibao Pharmaceutical (300039) — Capital Reinvestment Ratio
Latest as of September 2025:
0.02x
Shanghai Kaibao Pharmaceutical (300039) has a Capital Reinvestment Ratio of 0.02x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥190.98 Million) in capital expenditures (CN¥3.37 Million). See 300039 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.02x
Capex / Operating Cash Flow
Operating Cash Flow
CN¥190.98 Million
CNY
Capital Expenditures
CN¥3.37 Million
CNY
Data as of
Sep 2025
Most recent filing
Shanghai Kaibao Pharmaceutical Capital Reinvestment Ratio (2006–2024)
This chart tracks Shanghai Kaibao Pharmaceutical's Capital Reinvestment Ratio across 19 annual periods.
Annual Capital Reinvestment Ratio for Shanghai Kaibao Pharmaceutical (2006–2024)
Year-by-year Capital Reinvestment Ratio for Shanghai Kaibao Pharmaceutical from 2006 to 2024. For live market cap and broader valuation context, see market cap of Shanghai Kaibao Pharmaceutical.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.50x | CN¥278.95 Million | CN¥140.52 Million | ▲ +563.0% |
| 2023 | 0.08x | CN¥382.66 Million | CN¥29.08 Million | ▼ -9.5% |
| 2022 | 0.08x | CN¥376.42 Million | CN¥31.62 Million | ▼ -75.1% |
| 2021 | 0.34x | CN¥126.08 Million | CN¥42.55 Million | ▲ +506.8% |
| 2020 | 0.06x | CN¥250.65 Million | CN¥13.94 Million | ▲ +20.2% |
| 2019 | 0.05x | CN¥334.09 Million | CN¥15.46 Million | ▼ -53.4% |
| 2018 | 0.10x | CN¥262.36 Million | CN¥26.07 Million | ▼ -50.4% |
| 2017 | 0.20x | CN¥245.76 Million | CN¥49.24 Million | ▲ +133.4% |
| 2016 | 0.09x | CN¥314.88 Million | CN¥27.03 Million | ▼ -44.3% |
| 2015 | 0.15x | CN¥327.08 Million | CN¥50.40 Million | ▼ -36.7% |
| 2014 | 0.24x | CN¥282.38 Million | CN¥68.74 Million | ▼ -44.4% |
| 2013 | 0.44x | CN¥270.23 Million | CN¥118.28 Million | ▲ +104.0% |
| 2012 | 0.21x | CN¥243.32 Million | CN¥52.21 Million | ▼ -69.4% |
| 2011 | 0.70x | CN¥98.31 Million | CN¥68.85 Million | ▼ -72.8% |
| 2010 | 2.58x | CN¥19.79 Million | CN¥51.01 Million | ▲ +8.1% |
| 2009 | 2.38x | CN¥52.74 Million | CN¥125.70 Million | ▲ +294.9% |
| 2008 | 0.60x | CN¥18.70 Million | CN¥11.28 Million | ▲ +204.1% |
| 2007 | 0.20x | CN¥23.27 Million | CN¥4.62 Million | ▼ -66.7% |
| 2006 | 0.60x | CN¥19.70 Million | CN¥11.74 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow